Covidien Enters Hemorrhoidopexy Market with New Hemorrhoid Stapling Technology

Covidien (NYSE: COV), a leading global provider of healthcare products, is entering the hemorrhoidopexy market for the first time with an innovative circular stapling technology called the EEATM Hemorrhoid & Prolapse Stapler Set with DST SeriesTM Technology. The new instrumentation features a number of important advances in hemorrhoid stapler technology and design that addresses what surgeons say are their biggest challenges in performing the hemorrhoidopexy procedure. (Video: Business Wire) Business Wire press release available: www.businesswire.com